Tip 2 Diyabetli Kadınların Kontrasepsiyon Kullanım Davranışları: Bir Kamu Hastanesi Örneği

Yıl 2021, , 165 - 172, 29.08.2021

Selda Çelik , Feride Taşkın Yılmaz , Gülden Anataca Elif Bülbül

https://doi.org/10.25048/tudod.889587

Öz

Amaç: Araştırma, tip 2 diyabetli kadınların kontrasepsiyon kullanım davranışlarını ve ilişkili faktörleri belirlemek amacıyla yapılmıştır.
Gereç ve Yöntemler: Çalışmaya, bir kamu hastanesinde Diyabet polikliniğine başvuran ve üreme döneminde olan 194 tip 2 diyabetli kadın dahil edilmiştir. Veriler kadınların sosyodemografik ve hastalık özellikleri ile kontrasepsiyon yöntemi kullanmaya ilişkin bilgilerini sorgulayan tanılama formu ile elde edilmiştir. Verilerinin değerlendirilmesinde bağımsız gruplarda t testi ve Ki-kare testi kullanılmıştır.
Bulgular: Çalışmaya katılan diyabetli kadınların %54.6’sı kontrasepsiyon yöntemi kullandığını ve en fazla geri çekme (%40.5) ile kondom (%39.7) yönetimini tercih ettiğini belirtmiştir. Kadınların sadece %33.5’inin kontrasepsiyon konusunda sağlık profesyonellerinden bilgi aldığı tespit edilmiştir. Kontrasepsiyon kullanan kadınların %19.9’unun kontrasepsiyon seçimi için hekime danıştığı ve %38.6’sının ucuz/bedava olması nedeniyle kullandığı yöntemi tercih ettiği belirlenmiştir. Çalışmada üç ve üzeri çocuk sayısı bulunan ve kontrasepsiyon ile ilgili bilgi alan kadınların kontrasepsiyon kullanma oranlarının daha yüksek olduğu, bununla birlikte ileriye yönelik gebelik düşüncesi olmayan kadınların daha düşük oranda kontrasepsiyon kullandığı tespit edilmiştir.
Sonuç: Çalışmada diyabetli kadınların sadece yarısının kontrasepsiyon yöntemi kullandıkları, kontrasepsiyon kullanmada çocuk sayısının, kontrasepsiyon ile ilgili bilgi alma durumunun ve ileriye yönelik gebelik düşüncesinin ilişkili olduğu belirlenmiştir.

Anahtar Kelimeler

Tip 2 diyabet, Kontrasepsiyon, Aile planlaması

Contraception Usage Behavior of Women with Type 2 Diabetes: An Example of a Public Hospital

Öz

Aim: Planned pregnancy is important in terms of maternal and infant health in women with diabetes of reproductive age. In this period, it is necessary to use the correct contraception method to prevent unwanted pregnancies. The study was conducted to determine contraception use behaviors and related factors of women with type 2 diabetes.
Material and Methods: The study included 194 women with type 2 diabetes who applied to a diabetes outpatient clinic in a public hospital and were in their reproductive period. The data were obtained with a diagnosis form that inquired about the sociodemographic and disease characteristics of women and their knowledge about using contraception. In the evaluation of the data, t test and Chi-square test were used in independent groups.
Results: In the study, it was determined that 54.6% of the diabetic women used contraception method and preferred the most coitus interruptus (40.5%) and condom (39.7%) management. It was found that only 33.5% of women received information about contraception from health professionals. It was determined that 19.9% of the women using contraception consulted the physician for the choice of contraception and 38.6% preferred the method they used because it was cheap / free. In the study, it was found that women with three or more children and who received information about contraception had a higher rate of using contraception, however, women who had no prospective pregnancy thought used contraception at a lower rate.
Conclusion: In the study, it was determined that only half of the women with diabetes used contraception method. It was determined that the use of contraception and the number of children, the state of obtaining information about contraception and the prospective pregnancy idea were associated.

Anahtar Kelimeler

Type 2 diabetes, Contraception, Family planning, Behavior

Kaynakça

• 1. Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Research and Clinical Practice. 2019;157:107843.
• 2. Leow SN, Tang WS, Pararajasingam RP, Ee WS. Patient perception of pre-pregnancy care and family planning among reproductive-age female diabetes mellitus patients in a primary care clinic in Penang, Malaysia. Malays Fam Physician. 2020;15(3);35–42.
• 3. Robinson A, Nwolise C, Shawe J. Contraception for women with diabetes: challenges and solutions. Open Access Journal of Contraception. 2016;7:11–18.
• 4. Pallardo L.F, Cano A, Cristobal I, Blanco M.A, Lozano M, Lete I. Hormonal Contraception and Diabetes. Clinical Medicine Insights: Women’s Health. 2012;5:53–63. doi: 10.4137/CMWH.S9934
• 5. Aksu H, Gökdemirel SÖ. Diyabetli kadınlarda kontrasepsiyon seçimi. STED. 2012;21(2):70-73.
• 6. Shawe J, Smith P, Stephenson J. Use of contraception by women with type 1 or type 2 diabetes mellitus: ‘It's funny that nobody really spoke to me about it’. The European Journal of Contraception & Reproductive Health Care. 2011;16(5):350-358. doi: 10.3109/13625187.2011.597896
• 7. Shawe J, Lawrenson R. Hormonal contraception in women with diabetes mellitus: Special considerations Treatments in Endocrinology. 2003;2(5):321-230. doi: 10.2165/00024677-200302050-00004.
• 8. Watts S. Contraception advice for young people with diabetes. Buckinghamshire Healthcare. 2020.
• 9. Britton LE, Hussey JM, Berry DC, Crandell JL, Brooks JL, Bryant AG. Contraceptive use among women with prediabetes and diabetes in a US national sample. J Midwifery Womens Health. 2018;1–10. doi:10.1111/jmwh.12936
• 10. Damm R Mathıesen E, Clausen TD, Petersen KR. Contraception for women with diabetes mellitus. Metabolic Syndrome and Related Disorders Fall. 2005;3(3):244-249. doi: 10.1089/met.2005.3.244.
• 11. Walker SL, Anguzu R, Egede LE, Palatnik A. Contraception preferences in women with diabetes. Diabetes. 2020;69(Supp1). https://doi.org/10.2337/db20-1347-P
• 12. MacKay L, Glasier A, McKnight JA Contraception for women with diabetes mellitus. Pract Diab Int. 2005;22(2):49-52. https://doi.org/10.1002/pdi.748
• 13. Law DS, Tan CE, Tong SF. Influences on the decision to use contraception among Sarawakian women with diabetes: a qualitative exploration. Sex Reprod Health Matters. 2019;27(1):1571316. doi: 10.1080/09688080.2019.1571316
• 14. Schwarz EB, Maselli J, Gonzales R. Contaceptive counseling of diabetic women of reoroductive age. Obstet Gynecol. 2006;107(5):1070-1074. doi: 10.1097/01.AOG.0000216002.36799.b4
• 15. Shave J, Mulnier H, Nicholfs R, Lawrenson R. Use of hormonal contraceptive methods by women with diabetes. Prim Care Diabetes. 2008;2(4):195-199.
• 16. Nikolov A, Dimitrov A, Kolarov G, Todarova K, Mekhandzhiev TS. Contraception in women with diabetes mellitus. Akush Ginckol. 2005;44(5):47-52.
• 17. Visser J, Snel M, Van Vliet HA. Hormonal versus non-hormonal contraceptives in women with diabetes mellitus type 1 and 2. Cochrane Database Syst Rev. 2013;3:CD003990. http://dx.doi.org/10.1002/14651858.CD003990.pub4.
• 18. World Health Organization (WHO). Medical eligibility criteria for contraceptive use, Fifth edition, 2015. Geneva: WHO 2009. Accessed 20 February 2021 from: https://www.who.int/publications/i/item/9789241549158
• 19. Durand M, Armenta A. Contraception and Hormonal Therapy in Women with Diabetes Mellitus. J Diabetes Metab. 2015;6:554. doi:10.4172/2155-6156.1000554
• 20. Johnson EH, Wu J. Contraceptive decision making among women with diabetes mellitus: A mixed methods study. Journal of Clinical and Translational Science. 2020;4(1):127. https://doi.org/10.1017/cts.2020.378
• 21. Aksu H, Yurtsev E. Gebelik, diyabet ve hemşirelik bakımı. Hacettepe Üniversitesi Sağlık Bilimleri Fakültesi Hemşirelik Dergisi. 2009:50–58.
• 22. Vahratian A, Barber JS, Lawrence JM, Kim C. Family-planning practices among women with diabetes and overweight and obese women in the 2002 national survey for family growth. Diabetes Care. 2009;32:1026–1031.
• 23. Evangelista DR, Moura ERF, Costa CBJS, Bezerra CG, Valente MMQP, de Sousa CSP. Contraception: knowledge and practice among women with Diabetes Mellitus. Esc Anna Nery. 2014;18(3):441-447. doi: 10.5935/1414-8145.20140063